Literature DB >> 14522245

Monitoring the ubiquitin/proteasome system in conformational diseases.

Kristina Lindsten1, Nico P Dantuma.   

Abstract

Controlled proteolysis of regulatory or aberrant proteins by the ubiquitin/proteasome system is indispensable for cell viability. Conformational diseases such as Alzheimer's, Parkinson's and Huntington's disease are characterised by the accumulation of misfolded or aggregation-prone proteins. Since these proteins are typical substrates of the ubiquitin/proteasome system, it is not surprising that various models propose impairment of this system as a contributing factor to the pathology of conformational disorders. The complex nature of the ubiquitin/proteasome system and its universal role in cell physiology however turns evaluation of these attractive hypotheses into a major challenge. Several reporter substrates for the ubiquitin/proteasome system have recently been developed to facilitate functional studies of the system in living cells. In this review, we will discuss these new tools as well as the proteins associated with conformational disease that have been studied with these reporters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522245     DOI: 10.1016/s1568-1637(03)00031-x

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  9 in total

Review 1.  Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis.

Authors:  Adam T Melvin; Gregery S Woss; Jessica H Park; Marcey L Waters; Nancy L Allbritton
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

2.  Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.

Authors:  Elizabeth M H Tank; Heather L True
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

Review 3.  The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution.

Authors:  Nico P Dantuma; Laura C Bott
Journal:  Front Mol Neurosci       Date:  2014-07-31       Impact factor: 5.639

4.  Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury.

Authors:  Tobias Engel; Jaime Martinez-Villarreal; Christine Henke; Eva M Jimenez-Mateos; Amaya Sanz-Rodriguez; Mariana Alves; Yasmina Hernandez-Santana; Gary P Brennan; Aidan Kenny; Aoife Campbell; Jose J Lucas; David C Henshall
Journal:  Mol Neurodegener       Date:  2017-02-24       Impact factor: 14.195

5.  Visualizing Proteasome Activity and Intracellular Localization Using Fluorescent Proteins and Activity-Based Probes.

Authors:  Sabine Schipper-Krom; Alicia Sanz Sanz; Emma J van Bodegraven; Dave Speijer; Bogdan I Florea; Huib Ovaa; Eric A Reits
Journal:  Front Mol Biosci       Date:  2019-08-20

Review 6.  The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias.

Authors:  Janet E Davies; Sovan Sarkar; David C Rubinsztein
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

7.  Aging is not associated with proteasome impairment in UPS reporter mice.

Authors:  Casey Cook; Jennifer Gass; Judith Dunmore; Jimei Tong; Julie Taylor; Jason Eriksen; Eileen McGowan; Jada Lewis; Jennifer Johnston; Leonard Petrucelli
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

8.  27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons.

Authors:  Jared Schommer; Gurdeep Marwarha; Trevor Schommer; Travis Flick; Jonah Lund; Othman Ghribi
Journal:  BMC Neurosci       Date:  2018-04-03       Impact factor: 3.288

Review 9.  Fluorescent probes for proteolysis: tools for drug discovery.

Authors:  Jacques Neefjes; Nico P Dantuma
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.